Kinetic Barriers to Disproportionation of Salts of Weakly Basic Drugs
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.2c01034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Tu Van Duong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, Indiana47907, United States. Hauptthemen laut MEDLINE: Salts, Sodium Chloride. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: GlaxoSmithKline.
Abstract (Originalsprache)
Disproportionation is a major issue in formulations containing salts of weakly basic drugs. Despite considerable interest in risk assessment approaches for disproportionation, the prediction of salt-to-base conversion remains challenging. Recent studies have highlighted several confounding factors other than pHmax that appear to play an important role in salt disproportionation and have suggested that kinetic barriers need to be considered in addition to the thermodynamic driving force when assessing the risk of a salt to undergo conversion to parent free base. Herein, we describe the concurrent application of in situ Raman spectroscopy and pH monitoring to investigate the disproportionation kinetics of three model salts, pioglitazone hydrochloride, sorafenib tosylate, and atazanavir sulfate, in aqueous slurries. We found that even for favorable thermodynamic conditions (i.e., pH ≫ pHmax), disproportionation kinetics of the salts were very different despite each system having a similar pHmax. The importance of free base nucleation kinetics was highlighted by the observation that the disproportionation conversion time in the slurries showed the same trend as the free base nucleation induction time. Pioglitazone hydrochloride, with a free base induction time of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, Indiana47907, United States.
- GlaxoSmithKline, Park Road, Ware, SG12 0DP, U.K.
- GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, U.K.
ORCID-Profile: Tu Van Duong, Samir Diab, Neil S Hodnett, Lynne S Taylor
Förderung
- GlaxoSmithKline
Zitieren
APA
Van Duong, T., Diab, S., Hodnett, N. S., & Taylor, L. S. (2023). Kinetic Barriers to Disproportionation of Salts of Weakly Basic Drugs. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c01034
Vancouver
Van Duong T, Diab S, Hodnett NS, Taylor LS. Kinetic Barriers to Disproportionation of Salts of Weakly Basic Drugs. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c01034
BibTeX
@article{VanDuong2023,
author = {Van Duong, Tu and Diab, Samir and Hodnett, Neil S and Taylor, Lynne S},
title = {Kinetic Barriers to Disproportionation of Salts of Weakly Basic Drugs},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.2c01034}
}
EUVIMED